These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 7107352)
21. Misonidazole as a radiosensitizer in the radiotherapy of glioblastomas and oesophageal cancer. Pharmacokinetic and clinical studies. Tamulevicius P; Bamberg M; Scherer E; Streffer C Br J Radiol; 1981 Apr; 54(640):318-24. PubMed ID: 7013890 [TBL] [Abstract][Full Text] [Related]
22. A phase I/II study of the hypoxic cell sensitizer misonidazole as an adjunct to high fractional dose radiotherapy in patients with unresectable squamous cell carcinoma of the head and neck: a RTOG randomized study (#79-04). Lee DJ; Pajak TF; Stetz J; Order SE; Weissberg JB; Fischer JJ Int J Radiat Oncol Biol Phys; 1989 Feb; 16(2):465-70. PubMed ID: 2646255 [TBL] [Abstract][Full Text] [Related]
23. Misonidazole in the clinic at Mount Vernon. Dische S Cancer Clin Trials; 1980; 3(2):175-8. PubMed ID: 7000388 [TBL] [Abstract][Full Text] [Related]
24. The treatment of locally advanced head and neck cancer with misonidazole, hyperbaric oxygen and irradiation: an interim report. Sealy R; Cridland S Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1721-3. PubMed ID: 6384161 [TBL] [Abstract][Full Text] [Related]
25. Kinetics of misonidazole enantiomers. Williams KM Clin Pharmacol Ther; 1984 Dec; 36(6):817-23. PubMed ID: 6499361 [TBL] [Abstract][Full Text] [Related]
26. The value of adjuvant misonidazole in the definitive irradiation of advanced head and neck squamous cancer: an RTOG pilot study (#78-02). Fazekas JT; Goodman RL; McLean CJ Int J Radiat Oncol Biol Phys; 1981 Dec; 7(12):1703-8. PubMed ID: 7333912 [No Abstract] [Full Text] [Related]
27. Combined modality treatment of operated astrocytomas grade 3 and 4. A prospective and randomized study of misonidazole and radiotherapy with two different radiation schedules and subsequent CCNU chemotherapy. Stage II of a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Hatlevoll R; Lindegaard KF; Hagen S; Kristiansen K; Nesbakken R; Torvik A; Ganz JC; Mella O; Rosengren B; Ringkjöb R Cancer; 1985 Jul; 56(1):41-7. PubMed ID: 2988737 [TBL] [Abstract][Full Text] [Related]
28. Failure of misonidazole-sensitized radiotherapy to impact upon outcome among stage III-IV squamous cancers of the head and neck. Fazekas J; Pajak TF; Wasserman T; Marcial V; Davis L; Kramer S; Rotman M; Stetz J Int J Radiat Oncol Biol Phys; 1987 Aug; 13(8):1155-60. PubMed ID: 3301758 [TBL] [Abstract][Full Text] [Related]
29. Phenytoin-misonidazole: possible metabolic interaction. Gangji D; Schwade JG; Strong JM Cancer Treat Rep; 1980 Jan; 64(1):155-6. PubMed ID: 7379050 [TBL] [Abstract][Full Text] [Related]
30. Hyperfractionated radiotherapy with or without misonidazole: results of a prospective randomized study in stage III-IV squamous cell carcinoma of the head and neck. Panis X; Nguyen TD; Froissart D; Demange L Int J Radiat Oncol Biol Phys; 1984 Oct; 10(10):1845-9. PubMed ID: 6386760 [TBL] [Abstract][Full Text] [Related]
31. Effects of pretreatment with phenobarbitone and phenytoin on the pharmacokinetics and toxicity of phenytoin on the pharmacokinetics and toxicity of misonidazole in mice. Workman P Br J Cancer; 1979 Sep; 40(3):335-53. PubMed ID: 508562 [TBL] [Abstract][Full Text] [Related]
32. Phenytoin sodium-induced alterations in the pharmacokinetics of misonidazole in the dog. White RA; Workman P Cancer Treat Rep; 1980; 64(2-3):360-1. PubMed ID: 7190871 [No Abstract] [Full Text] [Related]
36. Misonidazole combined with large-fraction pelvic irradiation in the treatment of patients with advanced pelvic malignancies. Preliminary report of an ongoing RTOG phase I-II study. Meoz RT; Spanos WJ; Doss L; Johnson R; Wasserman TH Am J Clin Oncol; 1983 Aug; 6(4):417-22. PubMed ID: 6191560 [TBL] [Abstract][Full Text] [Related]
37. The combination of 5-fluorouracil with misonidazole in patients with advanced colorectal cancer. Spooner D; Bugden RD; Peckham MJ; Wist EA Int J Radiat Oncol Biol Phys; 1982; 8(3-4):387-9. PubMed ID: 7107357 [TBL] [Abstract][Full Text] [Related]
38. Irradiation with misonidazole and hyperbaric oxygen: final report on a randomized trial in advanced head and neck cancer. Sealy R; Cridland S; Barry L; Norris R Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1343-6. PubMed ID: 3531113 [TBL] [Abstract][Full Text] [Related]
39. Misonidazole and hemibody irradiation in the palliation of widespread metastases. Final report of an RTOG study. Zagars G; Salazar OM; Baird M; Phillips TL; Rubin P Am J Clin Oncol; 1985 Aug; 8(4):293-7. PubMed ID: 3909800 [TBL] [Abstract][Full Text] [Related]
40. The Cambridge glioma trial of misonidazole and radiation therapy with associated pharmacokinetic studies. Bleehen NM Cancer Clin Trials; 1980; 3(3):267-73. PubMed ID: 7002338 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]